Effect of specialist decision-making on treatment strategies for colorectal liver metastases

Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004)

(2012) T. Ruers et al.   ANNALS OF ONCOLOGY

Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial

(2010) C Garufi et al.   BRITISH JOURNAL OF CANCER

Liver resection of colorectal metastases in elderly patients

(2010) R. Adam et al.   BRITISH JOURNAL OF SURGERY

Surgical management and outcomes of colorectal cancer liver metastases

(2010) E. J. A. Morris et al.   BRITISH JOURNAL OF SURGERY

Optimum imaging of colorectal metastases

(2010) David J. Grand et al.   JOURNAL OF SURGICAL ONCOLOGY

Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial

(2010) Gianluca Masi et al.   LANCET ONCOLOGY

Evaluation of Long-term Survival After Hepatic Resection for Metastatic Colorectal Cancer

(2009) Myrddin Rees et al.   ANNALS OF SURGERY

Patients With Initially Unresectable Colorectal Liver Metastases: Is There a Possibility of Cure?

(2009) René Adam et al.   JOURNAL OF CLINICAL ONCOLOGY

Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial

(2009) Gunnar Folprecht et al.   LANCET ONCOLOGY